SCHEMBL900372

SCHEMBL900372

Cc1cccc(C(NC2CCN(C)CC2)c2nc3ccccc3[nH]2)c1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALPL P05186 1/20 0.41
▸ ALPI P09923 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ ALPG P10696 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ HRH4 Q9H3N8 4/20 0.41
▸ MLKL Q8NB16 2/20 0.40
▸ VCP P55072 4/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ HTR3A P46098 1/20 0.37
▸ LMNA P02545 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ PDE10A Q9Y233 1/20 0.36
▸ LPAR2 Q9HBW0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2722467 0.90 MLKL (0.43) ALPLKMT2ASMN1; SMN2HRH4MLKL
SCHEMBL2720358 0.89 HRH4 (0.45) ALPLMAPTKMT2ASMN1; SMN2HRH4
SCHEMBL2720674 0.89 HRH4 (0.40) HRH4VCPALDH1A1HTR3ALMNA
SCHEMBL2722093 0.89 KMT2A (0.41) KMT2AHRH4MLKLVCPALDH1A1
SCHEMBL2722838 0.89 HRH4 (0.40) ALPLKMT2ASMN1; SMN2HRH4MLKL
SCHEMBL2723739 0.89 VCP (0.40) ALPLKMT2AHRH4VCPHTR3A
SCHEMBL899828 0.89 HRH4 (0.42) KMT2ASMN1; SMN2HRH4MLKLVCP
SCHEMBL2722513 0.88 MLKL (0.51) MAPTKMT2ASMN1; SMN2KDM4EHRH4
SCHEMBL2720491 0.87 HRH4 (0.39) MAPTKMT2ASMN1; SMN2HRH4MLKL
SCHEMBL2720352 0.87 ALDH1A1 (0.44) HTTSMN1; SMN2KDM4EHRH4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3378476-A1 H4 RECEPTOR INHIBITORS FOR TREATING TINNITUS Sensorion (FR) 2018-09-26 — — EP disclosed
US-9688989-B2 H4 receptor inhibitors for treating tinnitus SENSORION (FR) 2017-06-27 — — US disclosed
EP-2621916-B1 BENZAZOLE DERIVATIVES AS HISTAMINE H4 RECEPTOR LIGANDS BIOPROJET SOC CIV (FR) 2016-02-10 — — EP disclosed
US-20150176010-A1 H4 RECEPTOR INHIBITORS FOR TREATING TINNITUS SENSORION (FR) 2015-06-25 — — US disclosed
EP-2447263-A1 Benzazole derivatives as histamine H4 receptor ligands BIOPROJET (FR) 2012-05-02 — — EP disclosed
Send feedback